Neuromodulation News and Research

RSS

Non-invasive trigeminal nerve stimulation shows promise in controlling seizures

Medications are the mainstay of treatment for epilepsy, but for a considerable number of patients - estimated to be as many as 1 million in the U.S. - drugs don't work. These patients suffer from a type of epilepsy known as refractory or drug-resistant epilepsy, in which drugs can't control their seizures.

26 May 2011

Nerve stimulation device approved for pain

The Medtronic Inc. has won the CE Mark approval for a peripheral nerve stimulation device for treating chronic back pain. This medical device maker from Minneapolis, Minn. said the implantable device will fit into its neurostimulation business, which operates out of the company's restorative therapies division. That unit was responsible for about $5.42 billion in sales during the nine-month period ended Jan. 28.

From Medtronic 24 May 2011

Uroplasty to present Urgent PC, Macroplastique products study data at upcoming meetings

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that the results of clinical studies using Uroplasty's Urgent PC Neuromodulation System and Macroplastique urethral bulking agent products are scheduled to be presented at three upcoming professional meetings.

25 Apr 2011

Medtronic's English Channel swimming competition to raise awareness on ALS

In August 2011, Doug McConnell of Barrington, Illinois, expects to be the 48th person over age 50 to successfully swim across the English Channel. He will be swimming more than 21 grueling miles in memory of his father, David, who passed away from ALS.

From Medtronic 25 Apr 2011

St. Jude Medical first quarter net sales increases 9% to $1.376 billion

St. Jude Medical, Inc. today reported sales and net earnings for the first quarter ended April 2, 2011.

20 Apr 2011

NHIC to cover PTNS using Uroplasty's Urgent PC Neuromodulation System for overactive bladder

Uroplasty, Inc. announced that NHIC Corp., the Medicare carrier for Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island and Vermont, will cover posterior tibial nerve stimulation (PTNS) using Uroplasty's Urgent® PC Neuromodulation System for the treatment of overactive bladder and associated symptoms, effective May 22, 2011.

8 Apr 2011

Positive results from Neuros Medical Electrical Nerve Block technology study in chronic pain

Neuros Medical, Inc., a medical device company, announced promising results today from their recently completed feasibility study. The study was the first human test of the Company's patented high frequency Electrical Nerve Block™ technology and focused on patients with chronic amputation pain which affects nearly one million patients in the U.S. During the study, four of the five patients reported their pain was reduced to zero.

7 Apr 2011

Insurance payers extend coverage for PTNS using Uroplasty's Urgent PC Neuromodulation System for OAB

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that two private insurance payers have elected to cover posterior tibial nerve stimulation (PTNS) using its Urgent PC Neuromodulation System for the treatment of overactive bladder (OAB) and associated symptoms.

5 Apr 2011

FDA approves Medtronic's InterStim Therapy to improve bowel control

Medtronic, Inc. today announced U.S. Food and Drug Administration approval of InterStim Therapy for Bowel Control. InterStim Therapy, previously available to treat the symptoms of overactive bladder and non-obstructive urinary retention, is now also approved for the treatment of chronic fecal incontinence in patients who have failed or are not candidates for more conservative treatments.

1 Apr 2011

Patients with low back pain can benefit from new spinal neuromodulation device

Results from an ongoing prospective study report that a novel spinal neuromodulation device changes the paradigm for patients suffering with low back pain who have not found relief through conventional spinal cord stimulation.

25 Mar 2011

FDA approves Boston Scientific's Clik Anchor for Precision Plus Spinal Cord Stimulator System

Boston Scientific Corporation today announced U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Clik™ Anchor for its Precision Plus™ Spinal Cord Stimulator (SCS) System, the world's first rechargeable SCS device for chronic pain management. The Clik Anchor features an innovative locking system designed to improve lead anchoring speed and consistency.

25 Mar 2011

Medtronic introduces Activa SC deep brain stimulation system in the U.S. and Europe

With the first U.S. implant of its new Activa SC neurostimulator for deep brain stimulation therapy, Medtronic, Inc. today announced the technology's commercial availability throughout the United States and Europe.

17 Mar 2011

Medtronic resolves FDA warning letters over Mounds View, Juncos facilities

Medtronic, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the company that issues noted in two warning letters -- one from November 2009 regarding the company's Mounds View, Minnesota facility and another from June 2009 regarding the company's manufacturing facility in Juncos, Puerto Rico -- have been resolved.

10 Mar 2011

St. Joseph's Hospital launches new neuromodulation center in Barrow

St. Joseph's Hospital and Medical Center's Barrow Neurological Institute has received a $10.1 million donation, the largest single gift in the organization's history and one of the biggest ever given to any Arizona hospital.

10 Mar 2011

Researcher launches new DBS clinical trial to pinpoint brain activity in depressed people

A top medical researcher at Barrow Neurological Institute at St. Joseph's Hospital in Phoenix, Arizona, has launched a clinical trial to pinpoint brain activity in depressed people by using scientifically designed sad and heartrending photos and music.

10 Mar 2011

Benefits and underutilization of ITB therapy for multiple sclerosis

A new scientific article has been published demonstrating the profound impact of spasticity on patients with multiple sclerosis and the benefits and underutilization of intrathecal baclofen (ITB) therapy from Medtronic, Inc. as a treatment option for these patients.

4 Feb 2011

Boston Scientific fourth quarter net sales decrease 4% to $2.002 billion

Boston Scientific Corporation today announced financial results for the fourth quarter and full year ended December 31, 2010, as well as net sales and earnings per share (EPS) guidance for the full year and first quarter 2011.

2 Feb 2011

New study on pain-relieving effect of transcutaneous Vagus Nerve Stimulation

The medical device company cerbomed cooperated with the Clinic for Psychiatry and Psychotherapy of the University of Regensburg 2010 on a randomized, controlled study into somatosensory pain processing. The study, lead by Prof. Dr. Peter Eichhammer and Dr. Volker Busch, aimed to judge the pain-relieving effect of transcutaneous Vagus Nerve Stimulation (t-VNS).

25 Jan 2011

St. Jude Medical's Athena programmer DBS system receives Australian TGA approval

St. Jude Medical, Inc., a global medical device company, today announced regulatory approval from the Australian Therapeutic Goods Administration (TGA) of its Athena™ programmer, a deep brain stimulation (DBS) therapy management system.

24 Jan 2011

Boston Scientific announces acquisition of Intelect Medical

Boston Scientific Corporation today announced it has acquired Intelect Medical, Inc., a development-stage company located in Boston. Intelect Medical is developing advanced neuromodulation technologies for deep brain stimulation therapy.

5 Jan 2011

Neuromodulation News and Research

Non-invasive trigeminal nerve stimulation shows promise in controlling seizures

Nerve stimulation device approved for pain

Uroplasty to present Urgent PC, Macroplastique products study data at upcoming meetings

Medtronic's English Channel swimming competition to raise awareness on ALS

St. Jude Medical first quarter net sales increases 9% to $1.376 billion

NHIC to cover PTNS using Uroplasty's Urgent PC Neuromodulation System for overactive bladder

Positive results from Neuros Medical Electrical Nerve Block technology study in chronic pain

Insurance payers extend coverage for PTNS using Uroplasty's Urgent PC Neuromodulation System for OAB

FDA approves Medtronic's InterStim Therapy to improve bowel control

Patients with low back pain can benefit from new spinal neuromodulation device

FDA approves Boston Scientific's Clik Anchor for Precision Plus Spinal Cord Stimulator System

Medtronic introduces Activa SC deep brain stimulation system in the U.S. and Europe

Medtronic resolves FDA warning letters over Mounds View, Juncos facilities

St. Joseph's Hospital launches new neuromodulation center in Barrow

Researcher launches new DBS clinical trial to pinpoint brain activity in depressed people

Benefits and underutilization of ITB therapy for multiple sclerosis

Boston Scientific fourth quarter net sales decrease 4% to $2.002 billion

New study on pain-relieving effect of transcutaneous Vagus Nerve Stimulation

St. Jude Medical's Athena programmer DBS system receives Australian TGA approval

Boston Scientific announces acquisition of Intelect Medical

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News